Circio Collaborates with TraffikGene to Enhance Non-Viral RNA Delivery
Circio, a company specializing in circular RNA expression technology, has partnered with the TraffikGene project at Universidad de Santiago de Compostela in Spain. The collaboration aims to advance non-viral delivery methods for circVec circular RNA expression vectors, which are used in gene and cell therapies. The partnership will leverage TraffikGene's peptide amphiphile carrier system to improve tissue targeting and delivery efficiency. The project will proceed through three stages: in vitro screening, optimization of formulations, and in vivo evaluation in mouse models. This collaboration seeks to unlock new therapeutic applications for circVec technology by enhancing delivery mechanisms. 
